Drug intelligence / Profile preview

measles + mumps + rubella vaccine + yellow fever vaccine

Development stage
Unknown
Lead developer
Parent
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

This drug entry refers to a co-administration regimen involving a live-attenuated measles, mumps, and rubella (MMR) vaccine and a live-attenuated yellow fever vaccine. Developed and evaluated by Sanofi, the regimen specifically focuses on the investigational Vero-cell derived yellow fever vaccine (vYF) compared to licensed egg-derived counterparts like Stamaril and YF-VAX. The combination is intended for pediatric populations, particularly infants and children aged 9 months to 5 years, to provide synchronized protection against measles, mumps, rubella, and yellow fever. Clinical evaluation in Phase III trials (such as VYF04) aims to demonstrate that simultaneous administration maintains the safety and immunogenicity of each individual component without interference.

Other names
MMR + YFvYF + MMRMMR vaccine + yellow fever vaccine

Beyond the preview

Go deeper on measles + mumps + rubella vaccine + yellow fever vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on measles + mumps + rubella vaccine + yellow fever vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call